Fig. 2.

Late gadolinium enhancement in cardiac magnetic resonance at baseline and follow up. Cardiac magnetic resonance imaging was performed in 12 patients (46.2% of the enrolled patients) at baseline and was repeated after the administration of nonsteroidal immunosuppressants in seven patients (26.9%). Late gadolinium enhancement was observed in 10 patients (38.5% of 26 patients) at baseline and in six patients (23.1%) at follow-up. CMR-LGE: late gadolinium enhancement on cardiac magnetic resonance.